Researchers find out why some lung tumors avoid immunotherapy, and learn how to predict this in advance
The oncogenic activation of MYC, a critical gene in cancer progression, has the potential to identify lung cancer patients who may respond poorly to immunotherapy (ICB). This is the main conclusion of a study recently published ...
Apr 14, 2023
0
54